Top Stories for the Week of Sept. 24th 2007

Friday, September 28, 2007 11:55 AM

Top News

 

Economic Modeling Company Caro Research Acquired by UBC

Maryland-based contract research organization (CRO) United BioSource Corporation (UBC) continued its acquisition flurry by purchasing Caro Research, a cost modeling and economic simulations provider based in Concord, Mass.

Accenture and Bristol-Myers Squibb Create Joint Pharmacovigilance Center in India

New York-based Accenture, a global consulting and outsourcing firm, and pharmaceutical company Bristol-Myers Squibb (BMS) have established a pharmacovigilance center in Chennai, India the first of its kind to monitor the pharmaceutical company's safety data. Accenture will contribute more than 140 employees to the center.

Other breaking news... 

  • Congress passes FDA Revitalization Act...
  • Green Mountain Logic inks deal with Qualia Clinical Services...      

Company Profile: An interview with and Mary-Ann Richardson, chief executive officer of African Clinical Research Organisation, and Christopher Whitfield, chief executive officer of Batswadi Pharmaceuticals, African Clinical Research Organisation.

To read the full articles for this issue or for more information on these and other breaking stories, pleaseclick herefor subscription information.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs